Penumbra Inc PEN:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/16/24 EDT
201.53quote price arrow down-3.17 (-1.55%)
Volume
273,269
52 week range
180.93 - 348.67
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close201.53
  • 52 Week High348.67
  • 52 Week High Date06/30/23
  • 52 Week Low180.93
  • 52 Week Low Date11/10/23

Key Stats

  • Market Cap7.812B
  • Shares Out38.76M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.61
  • YTD % Change-19.88

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close201.53
  • 52 Week High348.67
  • 52 Week High Date06/30/23
  • 52 Week Low180.93
  • 52 Week Low Date11/10/23
  • Market Cap7.812B
  • Shares Out38.76M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.61
  • YTD % Change-19.88

RATIOS/PROFITABILITY

  • EPS (TTM)2.38
  • P/E (TTM)84.78
  • Fwd P/E (NTM)71.29
  • EBITDA (TTM)124.06M
  • ROE (TTM)8.38%
  • Revenue (TTM)1.096B
  • Gross Margin (TTM)65.04%
  • Net Margin (TTM)8.52%
  • Debt To Equity (MRQ)2.11%

EVENTS

  • Earnings Date07/30/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Penumbra Inc

 

Profile

MORE
Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy...
Adam Elsesser J.D.
Chairman of the Board, President, Chief Executive Officer
Maggie Yuen
Chief Financial Officer
Lambert Shiu
Chief Accounting Officer
Johanna Roberts
Executive Vice President, General Counsel, Secretary
Address
One Penumbra Place
Alameda, CA
94502
United States

Top Peers

SYMBOLLASTCHG%CHG
RGEN
Repligen Corp
171.03-5.00-2.84%
LNTH
Lantheus Holdings Inc
81.10+1.50+1.88%
HAE
Haemonetics Corp
94.80-1.69-1.75%
MMSI
Merit Medical Systems Inc
82.26-1.49-1.78%
GMED
Globus Medical Inc
63.95-0.58-0.90%